The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans
出版年份 2019 全文链接
标题
The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans
作者
关键词
-
出版物
MOLECULAR PSYCHIATRY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-09-07
DOI
10.1038/s41380-019-0511-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dopamine, the antipsychotic molecule: A perspective on mechanisms underlying antipsychotic response variability
- (2018) Davide Amato et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment
- (2018) Diego Scheggia et al. Nature Communications
- Evidence of an epistatic effect between Dysbindin-1 and Neuritin-1 genes on the risk for schizophrenia spectrum disorders
- (2017) C. Prats et al. EUROPEAN PSYCHIATRY
- D3 Receptors Regulate Excitability in a Unique Class of Prefrontal Pyramidal Cells
- (2017) Rebecca L. Clarkson et al. JOURNAL OF NEUROSCIENCE
- Remote memories are enhanced by COMT activity through dysregulation of the endocannabinoid system in the prefrontal cortex
- (2017) D Scheggia et al. MOLECULAR PSYCHIATRY
- Dopamine transporter (DAT) genetic hypofunction in mice produces alterations consistent with ADHD but not schizophrenia or bipolar disorder
- (2017) M. Mereu et al. NEUROPHARMACOLOGY
- Buspirone Counteracts MK-801-Induced Schizophrenia-Like Phenotypes through Dopamine D3 Receptor Blockade
- (2017) Sebastiano Alfio Torrisi et al. Frontiers in Pharmacology
- The dopamine D3 receptor, a quarter century later
- (2016) Pierre Sokoloff et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Dysbindin-1 modifies signaling and cellular localization of recombinant, human D3 and D2 receptors
- (2016) Nathalie Schmieg et al. JOURNAL OF NEUROCHEMISTRY
- Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression
- (2016) Anthony A. Grace NATURE REVIEWS NEUROSCIENCE
- Current drug treatments targeting dopamine D3 receptor
- (2016) Gian Marco Leggio et al. PHARMACOLOGY & THERAPEUTICS
- Genetic Disruption of Arc/Arg3.1 in Mice Causes Alterations in Dopamine and Neurobehavioral Phenotypes Related to Schizophrenia
- (2016) Francesca Managò et al. Cell Reports
- Dopamine D3 Receptor Antagonists as Potential Therapeutics for the Treatment of Neurological Diseases
- (2016) Samuele Maramai et al. Frontiers in Neuroscience
- Sex-dichotomous effects of functional COMT genetic variations on cognitive functions disappear after menopause in both health and schizophrenia
- (2015) Francesco Papaleo et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Pharmacological targeting of dopamine D3 receptors: Possible clinical applications of selective drugs
- (2015) Emilio Merlo Pich et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The mRNA Expression Status of Dopamine Receptor D2, Dopamine Receptor D3 and DARPP-32 in T Lymphocytes of Patients with Early Psychosis
- (2015) Yin Cui et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- COMT Genetic Reduction Produces Sexually Divergent Effects on Cortical Anatomy and Working Memory in Mice and Humans
- (2014) Sara Sannino et al. CEREBRAL CORTEX
- Blonanserin Ameliorates Phencyclidine-Induced Visual-Recognition Memory Deficits: the Complex Mechanism of Blonanserin Action Involving D3-5-HT2A and D1-NMDA Receptors in the mPFC
- (2014) Hirotake Hida et al. NEUROPSYCHOPHARMACOLOGY
- The Ultimate Intra-/Extra-Dimensional Attentional Set-Shifting Task for Mice
- (2013) Diego Scheggia et al. BIOLOGICAL PSYCHIATRY
- The potential role of dopamine D3 receptor neurotransmission in cognition
- (2013) Shinichiro Nakajima et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Epistatic interaction between COMT and DTNBP1 modulates prefrontal function in mice and in humans
- (2013) F Papaleo et al. MOLECULAR PSYCHIATRY
- Chronic and Acute Intranasal Oxytocin Produce Divergent Social Effects in Mice
- (2013) Huiping Huang et al. NEUROPSYCHOPHARMACOLOGY
- Psychiatric Drugs Bind to Classical Targets Within Early Exocytotic Pathways: Therapeutic Effects
- (2012) Henry A. Lester et al. BIOLOGICAL PSYCHIATRY
- Synaptic Activity Unmasks Dopamine D2 Receptor Modulation of a Specific Class of Layer V Pyramidal Neurons in Prefrontal Cortex
- (2012) S. Gee et al. JOURNAL OF NEUROSCIENCE
- Use-Dependent Inhibition of Synaptic Transmission by the Secretion of Intravesicularly Accumulated Antipsychotic Drugs
- (2012) Carsten H. Tischbirek et al. NEURON
- Update: Studies of prepulse inhibition of startle, with particular relevance to the pathophysiology or treatment of Tourette Syndrome
- (2012) Neal R. Swerdlow NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Hypothesis review: are clathrin-mediated endocytosis and clathrin-dependent membrane and protein trafficking core pathophysiological processes in schizophrenia and bipolar disorder?
- (2011) K O Schubert et al. MOLECULAR PSYCHIATRY
- Mouse models of genetic effects on cognition: Relevance to schizophrenia
- (2011) Francesco Papaleo et al. NEUROPHARMACOLOGY
- Dysbindin and Schizophrenia: It's Dopamine and Glutamate All Over Again
- (2010) Francesco Papaleo et al. BIOLOGICAL PSYCHIATRY
- Dopamine D3Receptors Are Down-regulated following Heterologous Endocytosis by a Specific Interaction with G Protein-coupled Receptor-associated Sorting Protein-1
- (2010) Dawn Thompson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Projection-Specific Neuromodulation of Medial Prefrontal Cortex Neurons
- (2010) N. C. Dembrow et al. JOURNAL OF NEUROSCIENCE
- Dysbindin-1 modulates prefrontal cortical activity and schizophrenia-like behaviors via dopamine/D2 pathways
- (2010) F Papaleo et al. MOLECULAR PSYCHIATRY
- Effects of typical and atypical antipsychotic drugs on gene expression profiles in the liver of schizophrenia subjects
- (2009) Kwang H Choi et al. BMC Psychiatry
- Role of dysbindin in dopamine receptor trafficking and cortical GABA function
- (2009) Y. Ji et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Modeling the Positive Symptoms of Schizophrenia in Genetically Modified Mice: Pharmacology and Methodology Aspects
- (2009) M. van den Buuse SCHIZOPHRENIA BULLETIN
- Set-Shifting Ability and Schizophrenia: A Marker of Clinical Illness or an Intermediate Phenotype?
- (2008) Alan E. Ceaser et al. BIOLOGICAL PSYCHIATRY
- On the historical and conceptual background of the Wisconsin Card Sorting Test
- (2008) Paul Eling et al. BRAIN AND COGNITION
- Genetic Dissection of the Role of Catechol-O-Methyltransferase in Cognition and Stress Reactivity in Mice
- (2008) F. Papaleo et al. JOURNAL OF NEUROSCIENCE
- Habituation and sensitization of acoustic startle: Opposite influences of dopamine D1 and D2-family receptors
- (2008) Adam L. Halberstadt et al. NEUROBIOLOGY OF LEARNING AND MEMORY
- Antipsychotics differ in their ability to internalise human dopamine D2S and human serotonin 5-HT1A receptors in HEK293 cells
- (2007) Peter Heusler et al. EUROPEAN JOURNAL OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation